paramethasone has been researched along with Substance Withdrawal Syndrome in 1 studies
Paramethasone: A glucocorticoid with the general properties of corticosteroids. It has been used by mouth in the treatment of all conditions in which corticosteroid therapy is indicated except adrenal-deficiency states for which its lack of sodium-retaining properties makes it less suitable than HYDROCORTISONE with supplementary FLUDROCORTISONE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p737)
Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brinkmann, W | 1 |
| Klein, B | 1 |
| Möller, E | 1 |
1 trial available for paramethasone and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
[Is the rebound effect in liver diseases following glucocorticoid therapy avoidable by using alpha-lipoic acid?].
Topics: Chronic Disease; Drug Interactions; Humans; Liver Diseases; Paramethasone; Substance Withdrawal Synd | 1971 |